Glycopyrroniumbromid (Sialanar®) – Sialorrhea

1. Characteristics

Start date 01.04.2018
Resolution 20.09.2018
INN Glycopyrroniumbromid
Brand name Sialanar®
Company Proveca Limited
ATC code A03AB02
DDD 2 mg O
Therapeutic area Other OTHER
Reason for procedure New INN
Regulatory status PUMA

SubgroupIndicationComparator
Kinder und Jugendliche ab 3 Jahren mit chronischen neurologischen Erkrankungen Best-Supportive-Care (Placebo)

10. Associated procedures

Resolution INN Brand name Indication Additional benefit
GlycopyrroniumbromidSialanar®Sialorrhea


<< List of all resolutions